Using Success & Failure Roadmap Paves the Way for Positive New Product Launches in Oncology
CHAPEL HILL, N.C.- July 26, 2013- Recent pharmaceutical industry product launches have had uneven results, marked by launch success or failure factors. In the Oncology therapy area, in particular, utilizing new product launch success and failure guidelines can play a significant role in a launch's outcome.
In order to help launch leaders to effectively plan market entry strategies for their pipeline oncology products, benchmarking firm Best Practices, LLC developed a research report. The study, "Success Factors and Failure Points in Oncology Product Launches," delves deeper into the area of therapeutic product launches and identifies lessons learned, pitfalls and winning strategies of leaders in the Oncology therapeutic area.
The benchmarking report also addresses key issues that are integral to the success of a new product. Some key insights, best practices, and pitfalls harvested focused on:
- Winning on Differentiated Product Positioning
- Winning a Physician's Initial Trial of a New Product
- Articulating Benefits that Shape Positive Market Perception
- New Product Pricing Strategy
- Thought Leader Engagement
- Early Physician Education
- Payer Education
- Patient Advocacy and Education
The 173-page report delivers hard-to-find benchmarks that will allow executives to better examine industry standards in various areas. The research drew participation from 44 executives and managers from 38 leading pharmaceutical, biotech and medical device companies. In addition, field commentaries and insights were gained from 17 executives involved in launches.
To access the full report or to download a complimentary summary containing insights found in this report, click here.
For more information on this study or other recent primary research studies, contact us at 919.403.0251 or to learn more about best practices in new product launches and other benchmarking insights, visit our website at http://www.best-in-class.com.